Inventor
MASCARENHAS DESMOND
US30 patents
⚠️ This page may combine multiple inventors who share the name “MASCARENHAS DESMOND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELTRIX PHARMA
15 patentsUS5824467AOct 20, 1998
Methods for predicting drug response
CELTRIX PHARMA155 citations99
US6087090AJul 11, 2000
Methods for predicting drug response
CELTRIX PHARMA89 citations98
US5914254AJun 22, 1999
Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
CELTRIX PHARMA118 citations95
US5563046AOct 8, 1996
Fusion polypeptides and proteins
CELTRIX PHARMA52 citations95
US5470727ANov 28, 1995
Chromosomal expression of non-bacterial genes in bacterial cells
CELTRIX PHARMA69 citations95
US6514937B1Feb 4, 2003
Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
CELTRIX PHARMA24 citations92
US6025332AFeb 15, 2000
Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3
CELTRIX PHARMA16 citations92
US6025368AFeb 15, 2000
Method for treating the symptoms of chronic stress-related disorders using IGF
CELTRIX PHARMA29 citations91
US6015786AJan 18, 2000
Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
CELTRIX PHARMA33 citations91
US5830706ANov 3, 1998
Polypeptide fusions to polypeptides of the beta-trefoil fold structural family
CELTRIX PHARMA21 citations91
US5629172AMay 13, 1997
Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
CELTRIX PHARMA20 citations91
US6417330B1Jul 9, 2002
Insulin-like growth factor binding protein variants
CELTRIX PHARMA22 citations89
US6518238B1Feb 11, 2003
Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
CELTRIX PHARMA4 citations74
US5459051AOct 17, 1995
Methods and vectors for over-expression of ubiquitin fusion proteins in host cells
CELTRIX PHARMA12 citations74
US7288516B1Oct 30, 2007
Null IGF for the treatment of cancer
CELTRIX PHARMA0 citations52
BIOEXPERTISE LLC
4 patentsUS6914049B2Jul 5, 2005
IGF-binding protein-derived peptide or small molecule
BIOEXPERTISE LLC33 citations92
US6887851B2May 3, 2005
IGF-binding protein-derived peptide
BIOEXPERTISE LLC33 citations92
US6861406B2Mar 1, 2005
IGF-binding protein-derived peptide
BIOEXPERTISE LLC34 citations92
US7371813B2May 13, 2008
Method for use of IGF-binding protein for selective sensitization of target cells in vivo
BIOEXPERTISE LLC0 citations51
PROTIGEN INC
3 patentsUS7213032B2May 1, 2007
System and method for anonymous transaction in a data network and classification of individuals without knowing their real identity
PROTIGEN INC98 citations97
US8010400B2Aug 30, 2011
System and method for using psychological significance pattern information for matching with target information
PROTIGEN INC21 citations92
US7162432B2Jan 9, 2007
System and method for using psychological significance pattern information for matching with target information
PROTIGEN INC39 citations92
ONTHERIX INC
3 patentsMASCARENHAS DESMOND
3 patentsUS12102685B2Oct 1, 2024
Immodulator peptides covalently modified with small molecules
MASCARENHAS DESMOND0 citations59
US12410220B2Sep 9, 2025
Modulation of mammalian cell lineage by synthetic immodulins
MASCARENHAS DESMOND0 citations49
US8536135B2Sep 17, 2013
Adaptive biochemical signatures
MASCARENHAS DESMOND0 citations49